UK markets closed

Spineway Société Anonyme (ALSPW.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
0.00150.0000 (0.00%)
At close: 5:22PM CEST
Full screen
Previous close0.0015
BidN/A x N/A
AskN/A x N/A
Day's range0.0014 - 0.0015
52-week range0.0009 - 0.0041
Avg. volume94,115,054
Market cap33.949M
Beta (5Y monthly)2.57
PE ratio (TTM)N/A
EPS (TTM)-0.0050
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.88
  • Globe Newswire

    Half year 2021 SPINEWAY Sales Turnover : a positive growth and dynamic

    Press release Ecully, 13 July 2021 – 6 p.m. Revenue for the first half of 2021: +30% A dynamic and growth-promoting six monthsRecovery confirmed during the second quarter of 2021First step in building a European contender In an international context that is still disrupted by the global pandemic, Spineway recorded a 153% increase in revenue for the second quarter of 2021 compared with Q2 2020, driven by the recovery of its activity in its main territories and the integration of Distimp. This pos

  • Globe Newswire

    Accomplishment of the 1st stage of the external growth strategy - Confirmation of DISTIMP acquisition

    Press Release Ecully, 28 June 2021 - 6:00pm Acquisition of the company Distimp confirmed Spineway, specialist in innovative implants for the treatment of severe vertebral column (spine) disorders, announces the final signing to acquire 100% of the capital of Distimp, a French player in the spine surgery implants sector. This acquisition is part of the Group’s growth strategy and allows Spineway to expand its products and services to provide a wider range of implants and instruments for the treat

  • Globe Newswire

    Acquisition of Distimp - Signing of the MOU

    Press release Ecully, 1 June 2021 – 5 :45 p.m. Signature of a Memorandum of Understandingfor the acquisition of the Distimp start-up Spineway, specialized in innovative implants for the treatment of severe disorders of the spinal column (spine), signed a Memorandum of Understanding for the acquisition of 100% of the capital – subject to conditions precedent being met – of Distimp, a European start-up with which the Group began exclusive negotiations last March.1 Distimp, based in Nîmes, is speci